SAN ANTONIO--(BUSINESS WIRE)--Phoenix Biotechnology, Inc. (“Phoenix” or the “Company” www.phoenixbiotechnology.com) today announced ...
News
- Phoenix Biotechnology Announces Completion of Private Placement
- Biothera Pharmaceuticals Presents Updated Phase 2 Data for Chemo-refractory Triple Negative ...
... Chemo-refractory Triple Negative Breast Cancer Patients at San Antonio Breast Cancer Symposium .... About Biothera Pharmaceuticals, Inc.Biothera Pharmaceuticals is a privately held biotechnology company developing Imprime ...
- New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium
New Menarini CELLSEARCH Studies to be Presented at San Antonio ... biotechnology and diagnostics company headquartered in Florence, Italy, ...
- Tigerlily Foundation Hosts Historic Young Women's Metastatic Breast Cancer Disparities Fireside ...
... Disparities Fireside Chat at the San Antonio Breast Cancer Symposium ... Puma Biotechnology, Pfizer, Agendia, Amgen, Genentech, Lilly Oncology, ...
- BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally ...
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in ... the company's BJ-001 program at NEXT ONCOLOGY in San Antonio, Texas.